Table 2 Comparison of characteristics between patients with completed and uncompleted HBV screening

N

7,959

74,323

Age (years), Median (IQR)

69 (57–77)

70 (60–78)

 < 20

47 (0.6)

283 (0.4)

 20–39

466 (5.9)

3,120 (4.2)

 40–59

1,852 (23.3)

14,701 (19.8)

 60–79

4,150 (52.1)

40,070 (53.9)

 ≥80

1,444 (18.1)

16,149 (21.7)

Male, n (%)

2,474 (31.1)

19,226 (25.9)

<.0001*

Hospitalisation, n (%)

1,053 (13.2)

12,731 (17.1)

<.0001*

Prescribing department of rheumatology or orthopedics, n (%)

3,996 (50.2)

36,192 (48.7)

<.0001*

csDMARDs, n (%)

7,036 (88.4)

63,829 (85.9)

<.0001*

bDMARDs, n (%)

803 (10.1)

9,519 (12.8)

0.0103*

tsDMARDs, n (%)

120 (1.5)

975 (1.3)

0.1472

Steroid, n (%)

4,170 (52.4)

32,326 (43.5)

<.0001*

Injection, n (%)

820 (10.3)

9,625 (13.0)

<.0001*